Exploring prognostic microbiota markers in patients with endometrial carcinoma: Intratumoral insights

Exploring prognostic microbiota markers in patients with endometrial carcinoma: Intratumoral insights

Endometrial cancer, a leading gynecological malignancy, is profoundly influenced by the uterine microbiota, a key factor in disease prognosis and treatment. Our study underscores the distinct microbial compositions in endometrial cancer compared to adjacent non-cancerous tissues, revealing a dominan...

Full description

Bibliographic Details
Main Authors:	Jie Liu, Yi Qu, Yang-Yang Li, Ya-Lan Xu, Yi-Fang Yan, Hao Qin
Format:	Article
Language:	English
Published:	Elsevier 2024-03-01
Series:	Heliyon
Subjects:	Endometrial carcinoma TCGA-UCEC Risk score Microbial biomarker Prognostic signature
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844024039100

Similar Items

Inflammation-Related LncRNAs Signature for Prognosis and Immune Response Evaluation in Uterine Corpus Endometrial Carcinoma
by: Hongmei Gu, et al.
Published: (2022-06-01)

Overexpression of Nucleolin is a Potential Prognostic Marker in Endometrial Carcinoma
by: Lin Q, et al.
Published: (2021-02-01)

m6A RNA methylation regulator-based signature for prognostic prediction and its potential immunological role in uterine corpus endometrial carcinoma
by: Fang Fang, et al.
Published: (2022-12-01)

Identification of methylation-driven genes prognosis signature and immune microenvironment in uterus corpus endometrial cancer
by: JinHui Liu, et al.
Published: (2021-07-01)

Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Endometrial Cancer
by: Peigen Chen, et al.
Published: (2020-05-01)

A 13-Gene Signature Based on Estrogen Response Pathway for Predicting Survival and Immune Responses of Patients With UCEC
by: Yimin Li, et al.
Published: (2022-04-01)

Screening and validation of potential markers associated with uterine corpus endometrial carcinoma and polycystic ovary syndrome based on bioinformatics methods
by: Ruishan Wu, et al.
Published: (2023-06-01)

Metabolism-associated molecular classification of uterine corpus endometrial carcinoma
by: Munan Zhao, et al.
Published: (2023-01-01)

Prognostic Implications of Immune-Related Genes’ (IRGs) Signature Models in Cervical Cancer and Endometrial Cancer
by: Hao Ding, et al.
Published: (2020-07-01)

Establishment of a novel cell cycle-related prognostic signature predicting prognosis in patients with endometrial cancer
by: Jinhui Liu, et al.
Published: (2020-07-01)

COVID-19–associated lncRNAs as predictors of survival in uterine corpus endometrial carcinoma: A prognostic model
by: Yang Ding, et al.
Published: (2022-09-01)

Identification of Extracellular Matrix Signatures as Novel Potential Prognostic Biomarkers in Lung Adenocarcinoma
by: Zhen Zeng, et al.
Published: (2022-05-01)

Integrated Bioinformatic Analysis of a Competing Endogenous RNA Network Reveals a Prognostic Signature in Endometrial Cancer
by: Leilei Xia, et al.
Published: (2019-05-01)

Comprehensive Analysis of the Glycolysis-Related Gene Prognostic Signature and Immune Infiltration in Endometrial Cancer
by: Xiao Yang, et al.
Published: (2022-02-01)

Development and Clinical Validation of Novel 8-Gene Prognostic Signature Associated With the Proportion of Regulatory T Cells by Weighted Gene Co-Expression Network Analysis in Uterine Corpus Endometrial Carcinoma
by: Jinhui Liu, et al.
Published: (2021-12-01)

Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma
by: Jinzhi Lai, et al.
Published: (2022-03-01)

Mechanism of action of icaritin on uterine corpus endometrial carcinoma based on network pharmacology and experimental evaluation
by: Yan-Bin Jin, et al.
Published: (2023-07-01)

Genomic Instability of Mutation-Derived Gene Prognostic Signatures for Hepatocellular Carcinoma
by: Ze-Bing Song, et al.
Published: (2021-10-01)

Construction of a Prognostic Signature of 10 Autophagy-Related lncRNAs in Gastric Cancer
by: Wang W, et al.
Published: (2022-04-01)

Five-CpG-based prognostic signature for predicting survival in hepatocellular carcinoma patients
by: Feng Fang, et al.
Published: (2018-12-01)

Discovery of therapeutic targets of quercetin for endometrial carcinoma patients infected with COVID-19 through network pharmacology
by: Kehan Li, et al.
Published: (2023-03-01)

Tumor‐infiltrating immune cell score as an independent prognostic predictor for endometrial carcinoma: Insights from a comprehensive analysis of the immune landscape
by: Liping Zhang, et al.
Published: (2024-01-01)

RNA-binding protein with serine-rich domain 1 regulates microsatellite instability of uterine corpus endometrial adenocarcinoma
by: Xiaojuan Liu, et al.
Published: (2021-11-01)

Comprehensive Analysis and Experimental Validation of a Novel Estrogen/Progesterone-Related Prognostic Signature for Endometrial Cancer
by: Jing Yu, et al.
Published: (2022-05-01)

A prognostic model and immune regulation analysis of uterine corpus endometrial carcinoma based on cellular senescence
by: Lulu Gao, et al.
Published: (2022-12-01)

A comprehensive analysis and experimental validation of TK1 in uterine corpus endometrial carcinoma
by: Yiqing Sun, et al.
Published: (2024-03-01)

A Novel Prognostic Prediction Model Based on Pyroptosis-Related Clusters for Breast Cancer
by: Baoxing Tian, et al.
Published: (2022-12-01)

LGR5, a prognostic stem cell target, promotes endometrial cancer proliferation through autophagy activation
by: Chengcheng Li, et al.
Published: (2024-02-01)

Myelin and Lymphocyte Protein (MAL): A Novel Biomarker for Uterine Corpus Endometrial Carcinoma
by: Li D, et al.
Published: (2021-09-01)

Role of alternative splicing signatures in the prognosis of glioblastoma
by: Zu‐cheng Xie, et al.
Published: (2019-12-01)

Učeče se organizacije
by: Sabina Jelenc Krašovec
Published: (2000-12-01)

Exploring the mechanism and experimental verification of puerarin in the treatment of endometrial carcinoma based on network pharmacology and bioinformatics analysis
by: Zhiheng Lin, et al.
Published: (2022-06-01)

A novel cuproptosis-related gene signature for overall survival prediction in uterine corpus endometrial carcinoma (UCEC)
by: Shitong Lin, et al.
Published: (2023-04-01)

Characterization of coagulation-related gene signature to predict prognosis and tumor immune microenvironment in skin cutaneous melanoma
by: Binyu Song, et al.
Published: (2022-08-01)

A Novel Necroptosis-Related Gene Signature in Skin Cutaneous Melanoma Prognosis and Tumor Microenvironment
by: Binyu Song, et al.
Published: (2022-07-01)

Determining mutational burden and signature using RNA-seq from tumor-only samples
by: Erik Jessen, et al.
Published: (2021-03-01)

Identification of Immune-Related Prognostic Biomarkers Based on the Tumor Microenvironment in 20 Malignant Tumor Types With Poor Prognosis
by: Yu Liu, et al.
Published: (2020-07-01)

Six-lncRNA Immune Prognostic Signature for Cervical Cancer
by: Qian Chen, et al.
Published: (2020-10-01)

Mechanism investigation and experiment validation of capsaicin on uterine corpus endometrial carcinoma
by: Zhiheng Lin, et al.
Published: (2022-09-01)

Prognostic model of AU-rich genes predicting the prognosis of lung adenocarcinoma
by: Yong Liu, et al.
Published: (2021-10-01)